MYGENVIII
LIVE

Serial Number

90850017

Owner

BAYER ATKIENGESELLSCHAFT

Attorney

Phillip Barengolts

Filing Date

Jul 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MYGENVIII Trademark

Serial Number: 90850017 • Registration: 6988714

MYGENVIII is a trademark filed by BAYER ATKIENGESELLSCHAFT on July 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BAYER ATKIENGESELLSCHAFT (3 trademarks)

LEVERKUSEN-BAYERWERK , DE

Entity Type: 09

Trademark Details

Filing Date

July 27, 2021

Registration Date

February 28, 2023

Published for Opposition

December 13, 2022

Goods & Services

pharmaceutical products for the treatment of bleeding disorders; pharmaceutical products for the treatment of cardiovascular diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of diabetes; anti-infectives; pharmaceutical products for use in cell and gene therapy for the treatment of bleeding disorders, cardiovascular diseases, cancer, diabetes, and infections

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2024 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Nov 7, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 4, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2021 NWOS
NEW APPLICATION ENTERED
Jul 30, 2021 NWAP